Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Cash & Equivalents	170.57	176.5	99.81	1.57	4.72
Cash & Short-Term Investments	170.57	176.5	99.81	1.57	4.72
Cash Growth	89.91%	76.84%	6269.24%	-66.80%	-
Prepaid Expenses	1.12	2.25	1.04	0.21	-
Total Current Assets	171.69	178.74	100.84	1.78	4.72
Property, Plant & Equipment	0.11	0.09	-	-	-
Long-Term Deferred Charges	-	-	-	3.49	-
Other Long-Term Assets	0.7	0.7	-	-	-
Total Assets	172.5	179.53	100.84	5.26	4.72
Accounts Payable	1.25	0.73	2.75	2.01	0.01
Accrued Expenses	10.34	9.28	7.55	0.82	-
Short-Term Debt	-	-	-	7.76	-
Other Current Liabilities	9.5	9.5	10	4.23	0.03
Total Current Liabilities	21.09	19.51	20.3	14.82	0.04
Other Long-Term Liabilities	-	-	0.99	-	-
Total Liabilities	21.09	19.51	21.29	14.82	0.04
Common Stock	0.01	0.01	0	-	-
Additional Paid-In Capital	311.53	302.71	162.82	-	-
Retained Earnings	-173.34	-155.9	-103.49	-32.06	-7.82
Total Common Equity	138.2	146.82	59.33	-32.06	-7.82
Minority Interest	13.2	13.2	20.22	10	-
Shareholders' Equity	151.4	160.02	79.55	-9.56	4.68
Total Liabilities & Equity	172.5	179.53	100.84	5.26	4.72
Total Debt	-	-	-	7.76	-
Net Cash (Debt)	170.57	176.5	99.81	-6.19	4.72
Net Cash Growth	89.91%	76.84%	-	-	-
Net Cash Per Share	1.97	2.35	3.02	-27.13	-
Filing Date Shares Outstanding	61.87	68.37	43.59	43.09	17.25
Total Common Shares Outstanding	68.37	65.3	43.59	0.38	17.25
Working Capital	150.6	159.23	80.54	-13.04	4.68
Book Value Per Share	2.02	2.25	1.36	-83.59	-0.45
Tangible Book Value	138.2	146.82	59.33	-32.06	-7.82
Tangible Book Value Per Share	2.02	2.25	1.36	-83.59	-0.45

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q